Skip to content
★ Sign in to follow
Investview, Inc. logo

Investview, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by KOSOFF WILLIAM C, was filed 03 Aug 2017.

Investview, Inc.: what insiders have been doing

Investview, Inc., classified in the Finance & Banking sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Investview, Inc. The previous disclosure was published on 28 June 2022.

Since 2009, the database holds 56 purchases and 41 sales by insiders of the company. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 36.3 m USD and net income at -8.9 m USD.

In the same sector, recent insider purchases at BAWAG Group AG and Protector Forsikring ASA also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
153
Thresholds
n/a
Buy Volume
€2M
56 ops. · all time
Sell Volume
€8M
41 ops. · all time

Since the insiders bought

  • Filed 03 Aug 2017 · 3384 days ago · €272
    -37.6%
    Entry US$0.02 · Close at T+365 US$0.02
  • Filed 12 Jun 2014 · 4532 days ago · €368k
    -5.3%
    Entry US$0.95 · Close at T+365 US$0.90
  • Filed 03 Jan 2013 · 5057 days ago · €28k
    -37.9%
    Entry US$3.19 · Close at T+365 US$1.98

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,634 of 26,912 companies
20.0
score / 100
Value
11
Quality
29
FCF yld-14%
Earn yld-32%
EV/EBITDA·
ROE-168%
Gross mgn58%
Net mgn-27%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.02
Analyst consensus
·
Income statement
RevenueUS$36.3M
Gross profitUS$21M58% margin
EBITDA-US$7M-19% margin
Net income-US$9.7M-66.5% margin
Valuation
P/Book16.5x
Beta1.37
Balance sheet & cash
Market capUS$30.4M
Total debtUS$3.6M
Free Cash Flow-US$4.2M
Debt / Equity235%
Profitability & ownership
ROE-168.2%
ROA-36.0%
% insiders18.6%
% institutions0.0%
Last declaration on 28 June 2022
Declarations153 total
  • ●
    Chief Financial OfficerExecutives
    0SEC
    5,200,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-018013:0
  • ●
    President, Acting COO.Executives
    0SEC
    30,000,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-018010:0
  • ●
    DirectorExecutives
    0SEC
    33,333,334 shares0Common Stock, $0.001 par valueSEC:0001493152-22-018011:0
  • ●
    Chief Financial OfficerExecutives
    0SEC
    1,300,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-015347:0
  • ◆
    Director of FinanceExecutives
    862,039 USD11SEC
    21,550,970 shares@ US$0.042.7% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009641:2
  • ◆
    DirectorExecutives
    208,000 USD19SEC
    5,200,000 shares@ US$0.04100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009645:1
  • ◆
    Chief Operating OfficerExecutives
    862,039 USD11SEC
    21,550,970 shares@ US$0.042.7% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009643:2
  • ◆
    President, Acting COOExecutives
    187,200 USD19SEC
    4,680,000 shares@ US$0.04100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009639:1
  • ●
    Director of FinanceExecutives
    0SEC
    85,000,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-009641:1
  • ●
    Chief Operating OfficerExecutives
    0SEC
    85,000,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-009643:1
  • ◆
    President, Acting COOExecutives
    0SEC
    45,000,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-009639:0
  • ◆
    Director of FinanceExecutives
    62,372 USD19SEC
    1,559,293 shares@ US$0.04100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009641:0
  • ◆
    Chief Operating OfficerExecutives
    62,373 USD19SEC
    1,559,337 shares@ US$0.04100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-22-009643:0
  • ●
    DirectorExecutives
    0SEC
    50,000,000 shares0Common Stock, $0.001 par valueSEC:0001493152-22-009645:0
  • ●
    Chief Accounting OfficerExecutives
    0SEC
    6,666,667 shares0Common Stock, $0.001 par valueSEC:0001493152-21-027669:0
  • ▼
    Chief Operating OfficerExecutives
    1M USD27SEC
    40,000,000 shares@ US$0.02537.6% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-018564:0
  • ▼
    TreasurerExecutives
    1M USD35SEC
    40,000,000 shares@ US$0.02537.6% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-018566:0
  • ▼
    10% OwnerExecutives

    Same trade as the filing by Chad Miller, counted once

    1M USD25SEC
    106,000,000 shares@ US$0.013485.9% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-018411:0
  • ▼
    10% OwnerExecutives
    1M USD25SEC
    106,000,000 shares@ US$0.013485.9% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-018474:0
  • ●
    TreasurerExecutives
    1M USD23SEC
    50,000,000 shares@ US$0.02543.2% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-016834:0
  • ●
    Chief Operating OfficerExecutives
    1M USD15SEC
    50,000,000 shares@ US$0.02543.2% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-016836:0
  • ●
    DirectorExecutives
    450,000 USD13SEC
    15,000,000 shares@ US$0.0317.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-008557:0
  • ▼
    DirectorExecutives
    62,500 USD26SEC
    6,250,000 shares@ US$0.014.1% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-008560:0
  • ▼
    DirectorExecutives
    150,000 USD27SEC
    15,000,000 shares@ US$0.019.9% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-008560:1
  • ▼
    Corporate SecretaryExecutives
    13,000 USD30SEC
    1,000,000 shares@ US$0.013100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-20-008558:0

25 of 153 declarations

About Investview, Inc.

Investview, Inc. is a U.S.-based company headquartered in Haverford, Pennsylvania, United States. It is currently quoted on the OTCQB under the symbol INVU rather than on the NYSE or NASDAQ, and its corporate profile has evolved through several strategic shifts over time. Today, Investview presents itself as a diversified financial technology and consumer-products group, with a business model built around multiple operating subsidiaries spanning financial education, blockchain and Bitcoin mining, wellness manufacturing, and early-stage brokerage initiatives. ([investview.com](https://investview.com/?utm_source=openai))

At the core of the company’s historical franchise is its financial-education and self-directed investing platform, originally built through iGenius and now rebranded as Conectiv. This segment provides research, educational tools, content, and investor-support services aimed at retail, self-directed market participants. Distribution is largely organized through a global network of independent members and distributors, which gives the company a community-driven go-to-market model that is distinct from conventional brokerage or asset-management businesses. From a competitive standpoint, Investview occupies a niche at the intersection of fintech, education, and network marketing. That can be a differentiator, but it also makes the business model more exposed to regulatory scrutiny, reputational risk, and execution challenges than a more traditional financial-services platform. ([stage.investview.com](https://www.stage.investview.com/?utm_source=openai))

Read moreShow less

Investview has also broadened its scope beyond financial education. SAFETek is the company’s Bitcoin mining and blockchain infrastructure initiative, positioned as a sustainable, low-cost mining platform. Renu Laboratories operates as a manufacturing and development arm focused on private-label and contract manufacturing for skincare, personal care, hair care, cosmetic, and pharmaceutical topical products. In addition, the company launched myLife Wellness as a consumer health-and-wellness unit, and it continues to develop Opencash Securities and related trading-platform capabilities with the stated objective of offering self-directed retail brokerage services. This portfolio creates multiple potential revenue streams, but it also increases operational complexity and the importance of capital allocation discipline. ([stage.investview.com](https://www.stage.investview.com/?utm_source=openai))

Geographically, the business remains primarily tied to the United States, although its distribution model and product ambitions are described as global in scope. Recent milestones include the official launch of myLife Wellness in March 2026, the rebrand of iGenius to Conectiv in March 2026, and a board refresh announced in February 2026. The company’s 2025 Form 10-K also confirms that it continues to position itself as a multi-unit operating company rather than a single-product fintech. For investors, Investview should be viewed as a small-cap, higher-risk, event-driven story where valuation is likely to be driven by the commercialization of new initiatives, the performance of the bitcoin-mining and wellness units, and the company’s ability to convert its platform strategy into sustainable cash generation. ([investview.com](https://investview.com/news/?utm_source=openai))

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations